Hepatic arterial infusion of Corynebacterium parvum and chemotherapy.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002277:Carcinoma / Q000188:drug therapy / Q000628:therapy*; D002404:Catheterization; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000628:therapy*; D009362:Neoplasm Metastasis; D011425:Propionibacterium acnes / Q000276:immunology
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D005467:Floxuridine